Profilo
Eric Rojas is currently the Vice President of Investor Relations at Stoke Therapeutics, Inc. He previously worked as a Senior Director of Investor Relations at Shire Plc.
Posizioni attive di Eric Rojas
| Società | Posizione | Inizio |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Contatto Relazioni con gli Investitori | - |
Precedenti posizioni note di Eric Rojas
| Società | Posizione | Fine |
|---|---|---|
| SHIRE | Contatto Relazioni con gli Investitori | - |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| STOKE THERAPEUTICS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Borsa valori
- Insiders
- Eric Rojas
